Compositions and methods for inhibition of the JAK pathway
US7491732B2 · kind B2 · utility
89Cited by
36References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2006 |
| Grant date | Feb 17, 2009 |
| Priority date | — |
| Expiry date | Jun 8, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D285/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.